Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Postpartum Heparin Therapy for Patients with the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelets (HELLP) is Associated with Significant Hemorrhagic Complications

Journal of Perinatology volume 25, pages 236–240 (2005)Cite this article

Abstract

OBJECTIVE:

To compare the outcome of two groups of 16 patients with hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome treated with heparin therapy or treated conservatively in the postpartum period.

STUDY DESIGN:

This is a retrospective cohort study comparing 16 consecutive patients with HELLP syndrome admitted to the ICU at the University of Florence (Italy) after delivery and treated with heparin, to 16 patients with the same disease admitted to the University of Virginia (UVA, USA) and treated with supportive therapy.

RESULTS:

Nine patients in the Florence group developed disseminated intravascular coagulation (DIC). Six of them developed postpartum hemorrhage that was medically and surgically controlled. Five hysterectomies were performed and seven other laparotomies were necessary in four patients to control further bleeding complications. In the UVA group, one patient developed DIC and another one a retroperitoneal hematoma that resolved with no need for surgical intervention.

CONCLUSIONS:

Heparin therapy for postpartum patients with HELLP syndrome was associated with bleeding complications. We speculate that the heparin therapy was the cause for the bleeding complications occurred in the Florence group of patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Weinstein L . Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982;142:159–167.

    Article  CAS  Google Scholar 

  2. Van Dam PA, Reiner M, Baekelandt M, Buytaert P, Uyttenbroeck F . Disseminated intravascular coagulation and the syndrome of hemolysis, elevated liver enzymes and low platelets in severe preeclampsia. Obstet Gynecol 1989;73:97–102.

    CAS  PubMed  Google Scholar 

  3. Visser W, Wallenburg HCS . Temporising management of severe pre-eclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol 1995;102:111–117.

    Article  CAS  Google Scholar 

  4. Magann EF, Bass D, Chauhan SP, Sullivan L, Martin RW, Martin Jr JN . Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994;171:1148–1153.

    Article  CAS  Google Scholar 

  5. Brain MC, Baker LRI, McBride JA, Rubenberg ML, Dacie JV . Treatment of patients with microangiopathic haemolytic anaemia with heparin. Br J Haematol 1968;15:603–621.

    Article  CAS  Google Scholar 

  6. Butler BC, Taylor Sr HC, Graff S . The relationship of disorders of the blood clotting mechanism to toxemia of pregnancy and the value of heparin therapy. Am J Obstet Gynecol 1950;60:564–574.

    Article  CAS  Google Scholar 

  7. Howie PW, Prentice CRM, Forbes CD . Failure of heparin therapy to affect the clinical course of severe pre-eclampsia. Br J Obstet Gynaecol 1975;82:711–717.

    Article  CAS  Google Scholar 

  8. Goldsmith HJ, Menzies DN, De Boer CH, Caplan W, McCandless A . Delivery of healthy infant after five weeks’ dialysis treatment for fulminating toxaemia of pregnancy. Lancet 1971;2:738–741.

    Article  CAS  Google Scholar 

  9. Thiagarajah S, Wheby MS, Jain R, May HV, Bourgeois J, Kitchin III JD . Disseminated intravascular coagulation in pregnancy. The role of heparin therapy. J Reprod Med 1981;26:17–20.

    CAS  PubMed  Google Scholar 

  10. Heene DL . Disseminated intravascular coagulation: evaluation of therapeutic approaches. Semin Thromb Hemost 1977;3:291–310.

    Article  Google Scholar 

  11. Feinstein DI . Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy. Blood 1982;60:284–287.

    CAS  PubMed  Google Scholar 

  12. Sher G, Statland BE . Abruptio placentae with coagulopathy: a rational basis for management. Clin Obstet Gynecol 1985;28:15–23.

    Article  CAS  Google Scholar 

  13. Sibai BM, Anderson GD, McCubbin JH . Eclampsia. II. Clinical significance of laboratory findings. Obstet Gynecol 1982;59:153–157.

    CAS  PubMed  Google Scholar 

  14. Sibai BM . The HELLP syndrome (hemolysis, elevated liver enzymes and low platelets): much ado about nothing? Am J Obstet Gynecol 1990; 162:311–316.

    Article  CAS  Google Scholar 

  15. Hellgren M, Egberg N, Eklund J . Blood coagulation and fibrinolytic factors and their inhibitors in critically ill patients. Intens Care Med 1984;10:23–28.

    Article  CAS  Google Scholar 

  16. Bick RL . Disseminated intravascular coagulation. Objective clinical and laboratory diagnosis, treatment, and assessment of therapeutic response. Semin Thromb Hemost 1996;22:69–88.

    Article  CAS  Google Scholar 

  17. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA . Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169:1000–1006.

    Article  CAS  Google Scholar 

  18. Martin JN, Reiehart BK, May WL, Magann EF, Terrone DA, Blake PG . The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome classification. Am J Obstet Gynecol 1999;180:1373–1384.

    Article  Google Scholar 

  19. Sibai BM, Taslimi MM, El-Naser A, Amor E, Mabie BL, Ryan GM . Maternal–perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia–eclampsia. Am J Obstet Gynecol 1986;155:501–509.

    Article  CAS  Google Scholar 

  20. Martin Jr JN, Blake PG, Lowry SL, Perry KG, Files JC, Morrison JC . Pregnancy complicated by preeclampsia–eclampsia with the syndrome of hemolysis, elevated liver enzymes, and low platelet count: how rapid is postpartum recovery? Obstet Gynecol 1990;76:737–741.

    Article  Google Scholar 

  21. Magann EF, Perry KJ, Meydrech EF, Harris RL, Chauhan SP, Martin Jr JN . Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994;171:1154–1158.

    Article  CAS  Google Scholar 

  22. Martin Jr JN, Perry Jr KG, Blake PG, May WA, Moore A, Robinette L . Better maternal outcomes are achieved with dexamethasone therapy for post-partum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome. Am J Obstet Gynecol 1997;177:1011–1017.

    Article  Google Scholar 

  23. Skelly H, Morivate M, Norman R, Kenoyer G, Martin R . Consumptive coagulopathy following fetal death in a triplet pregnancy. Am J Obstet Gynecol 1982;142:595–596.

    Article  CAS  Google Scholar 

  24. Romero R, Duffy TP, Berkowitz RL, Chang E, Hobbins JC . Prolongation of a preterm pregnancy complicated by death of a single twin in utero and disseminated intravascular coagulation. N Engl J Med 1984;310:772–773.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI, USA

    Laura Detti MD

  2. Department of Obstetrics and Gynecology, University of Florence School of Medicine, Florence, Italy

    Federico Mecacci MD, Lucia Carignani MD, Giorgio Mello MD & Gianfranco Scarselli MD

  3. Department of Anesthesiology, University of Florence School of Medicine, Florence, Italy

    Anna Piccioli MD & Sante Ferrarello MD

  4. Department of Obstetrics and Gynecology, University of Kentucky, Lexington, KY, USA

    James E Ferguson MD

Authors
  1. Laura Detti MD
    View author publications

    Search author on:PubMed Google Scholar

  2. Federico Mecacci MD
    View author publications

    Search author on:PubMed Google Scholar

  3. Anna Piccioli MD
    View author publications

    Search author on:PubMed Google Scholar

  4. Sante Ferrarello MD
    View author publications

    Search author on:PubMed Google Scholar

  5. Lucia Carignani MD
    View author publications

    Search author on:PubMed Google Scholar

  6. Giorgio Mello MD
    View author publications

    Search author on:PubMed Google Scholar

  7. James E Ferguson MD
    View author publications

    Search author on:PubMed Google Scholar

  8. Gianfranco Scarselli MD
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Detti, L., Mecacci, F., Piccioli, A. et al. Postpartum Heparin Therapy for Patients with the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelets (HELLP) is Associated with Significant Hemorrhagic Complications. J Perinatol 25, 236–240 (2005). https://doi.org/10.1038/sj.jp.7211265

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.jp.7211265

This article is cited by

Search

Advanced search

Quick links